These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1988690)

  • 21. [The diagnosis of thyroid carcinoma].
    Sandrock D; Munz DL
    Dtsch Med Wochenschr; 1991 Jan; 116(2):77-8. PubMed ID: 1985815
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monoclonal antibodies in cancer therapy].
    Pfizenmaier K; Nagel GA
    Dtsch Med Wochenschr; 1985 Apr; 110(16):615-7. PubMed ID: 3886339
    [No Abstract]   [Full Text] [Related]  

  • 23. Imaging fresh venous thrombi in the dog with I-131 and In-111 labeled fibrin-specific monoclonal antibody and F(ab')2 fragments.
    Grossman ZD; Rosebrough SF; McAfee JG; Subramanian G; Ritter-Hrncirik CA; Witanowski LS; Tillapaugh-Fay G; Urrutia E
    Radiographics; 1987 Sep; 7(5):913-21. PubMed ID: 3454034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioimmunodetection of cancer].
    Itoh K; Nishi S; Hata Y
    Nihon Rinsho; 1986 Mar; 44(3):729-42. PubMed ID: 3525900
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
    Larson SM
    Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoimaging of human bladder tumor xenografts in nude mice by using monoclonal antibodies.
    Sakahara H; Endo K; Koizumi M; Nakashima T; Okada K; Yoshida O; Masuko T; Hashimoto Y; Torizuka K
    Jpn J Cancer Res; 1986 Sep; 77(9):916-21. PubMed ID: 3095288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro binding to granulocytes of two anti-NCA 95 monoclonal antibodies: Mab1 (ORIS) and Mabgc (Mallinckrodt).
    Collet B; Moisan A; Maros S; Toujas L; Herry JY
    Prog Clin Biol Res; 1990; 355():293-8. PubMed ID: 2281109
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possibilities of using monoclonal antibodies to CEA in scintigraphic diagnosis of tumors].
    Steenbeck L; Markwardt J
    Arch Geschwulstforsch; 1985; 55(3):207-14. PubMed ID: 3896190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiolabeled monoclonal antibody being studied as "vaccine" in ovarian cancer patients.
    Oncology (Williston Park); 1993 May; 7(5):57. PubMed ID: 8512783
    [No Abstract]   [Full Text] [Related]  

  • 30. Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
    Goldenberg DM
    Prog Clin Biol Res; 1989; 288():413-27. PubMed ID: 2654957
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody transport and internalization into tumours.
    Matzku S; Moldenhauer G; Kalthoff H; Canevari S; Colnaghi M; Schuhmacher J; Bihl H
    Br J Cancer Suppl; 1990 Jul; 10():1-5. PubMed ID: 2383472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of traditional methods of measuring tracer biodistributions.
    Williams LE
    Cancer Res; 1984 Jun; 44(6):2731-2. PubMed ID: 6732902
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer.
    Pietersz GA; Kanellos J; Smyth MJ; Zalcberg J; McKenzie IF
    Immunol Cell Biol; 1987 Apr; 65 ( Pt 2)():111-25. PubMed ID: 3301638
    [No Abstract]   [Full Text] [Related]  

  • 34. Numerical comparison of iodine-based and indium-based antibody biodistributions.
    Williams LE; Wu AM; Kenanova VE; Olafsen T; Yazaki PJ
    Cancer Biother Radiopharm; 2014 Apr; 29(3):91-8. PubMed ID: 24443889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy.
    Boniface GR; Izard ME; Walker KZ; McKay DR; Sorby PJ; Turner JH; Morris JG
    J Nucl Med; 1989 May; 30(5):683-91. PubMed ID: 2785586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies and immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS; Pimm MV
    Cancer Chemother Biol Response Modif; 1988; 10():397-415. PubMed ID: 3079393
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
    Juweid ME; Stadtmauer E; Hajjar G; Sharkey RM; Suleiman S; Luger S; Swayne LC; Alavi A; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3292s-3303s. PubMed ID: 10541378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White blood cell scintigraphy. Problems related to the use of monoclonal antibodies.
    Locher JT; Seybold K
    Prog Clin Biol Res; 1990; 355():327-36. PubMed ID: 2126379
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on radiopharmaceuticals for medical imaging.
    McAfee JG
    Radiology; 1989 Jun; 171(3):593-601. PubMed ID: 2654998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.